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N-methyl-D-aspartate receptors (NMDAR) are involved in neuronal plasticity. To assess
their role simultaneously in spatial working memory and non-cognitive learning, we used
NMDAR antagonists and the Allothetic Place Avoidance Alternation Task (APAAT). In
this test rats should avoid entering a place where shocks were presented on a rotating
arena which requires cognitive coordination for the segregation of stimuli. The experiment
took place 30min after intraperitoneal injection of memantine (5, 10, 20mg/kg b.w.:
MemL, MemM, MemH, respectively) and (+)MK-801 (0.1, 0.2, 0.3mg/kg b.w.: MK-801L,
MK-801M, MK-801H, respectively). Rats from the control group were intact or injected
with saline (0.2ml/kg). Over three consecutive days the rats underwent habituation,
two avoidance training intervals with shocks, and a retrieval test. The shock sector was
alternated daily. The after-effects of the agents were tested on Day 21. Rats treated with
low dose memantine presented a longer maximum time avoided and fewer entrances than
the MemH, MK-801M, MK-801H and Control rats. The shocks per entrances ratio, used
as an index of cognitive skill learning, showed skill improvement after D1, except for rats
treated by high doses of the agents. The activity levels, indicated by the distance walked,
were higher for the groups treated with high doses of the agents. On D21 the MK801H
rats performed the memory task better than the MemH rats, whereas the rats’ activity
depended on condition, not on the group factor. These results suggest that in naïve rats
mild NMDAR blockade by low-dose memantine improves working memory related to a
highly challenging task.
Keywords: working memory, cognitive skill learning, locomotor activity, MK-801, memantine, Allothetic Place
Avoidance Alternation Task (APAAT)
RESEARCH HIGHLIGHTS
Improvement of working memory was induced by low dose
memantine;
The negative effects of high doses on cognitive function were
diminished after a long break post-MK-801 administration, but
not post-memantine.
The APAAT is a useful behavioral tool to study the effects
of pharmacological treatments on both non-cognitive functions
and the cognitive functions, learning, memory and executive
functions.
INTRODUCTION
Working memory is fundamental for sustaining successful daily
activity in humans and animals. The brain areas involved in
working memory include the prefrontal cortex, hippocampus
and subcortical areas (Goldman-Rakic, 1995; Westerberg and
Klingberg, 2007; Heuer and Bachevalier, 2012). The prelimbic
and medial orbital cortices are part of the rat homologs of the
human prefrontal cortex, which receive hippocampal projections
from the ventral CA1 of the Ammon’s horn and subiculum (Jay
and Witter, 1991). A functional hippocampal-prefrontal network
has been documented in the rat brain (Schwarz et al., 2013) and
was found to be engaged in the rapid acquisition and short-term
maintenance of spatial information (Burette et al., 2000). The
prelimbic cortex is reciprocally connected with the rest of the pre-
frontal cortex (Jay and Witter, 1991); hence this area is capable
of functionally integrating contributions from the hippocampus
and prefrontal cortex, which further validate their participation
in spatial working memory.
In human working memory function, temporary storage
of current information occurs simultaneously along with the
execution of higher cognitive function and skill performance
(Baddeley, 1992; Repovs and Baddeley, 2006). It involves a
multi-component system of short-term and long-term memory,
which is distinguished by low and high capacities for infor-
mation retention (Cowan, 2008). Animal models of working
memory have utilized delayed alternation, the radial maze test,
the water maze and the place avoidance test for their assess-
ment (Dudchenko, 2004). The latter of these tasks, the place
avoidance test with alternation of the target sector, involves a
new set of spatial information about the task but does not
require prior skill pretraining, which permits demonstration of
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skill improvement across time through training (Dockery and
Wesierska, 2010).
It has been proven, that repetitive working memory training
of a spatial task promotes improvement in the general learning
performance and cognitive abilities (Klingberg, 2010). This
improvement is known as cognitive skill learning (CSL), and
just as for working memory in humans, it is domain-specific
(e.g., visual-spatial or phonological information), and results in
task-relevant improvements in terms of storage and assessment
(Olesen et al., 2004; Lee et al., 2007). During CSL, such as evoked
by exposure to novel task conditions, various learning mech-
anisms are involved including both declarative knowledge and
procedural form (Anderson et al., 1997). CSL requires associative
memory processes and intact fronto-striatal circuitry (Poldrack
et al., 1999), in addition to normal activity in the dorsolateral
prefrontal cortex (DLPFC) and the hippocampus (Cerella et al.,
2006). Furthermore, there is a relationship between spatial work-
ing memory performance and motor skill learning, whereby spa-
tial working memory, particularly in early learning, is predictive
of the rate of motor learning in humans (specifically sensorimo-
tor adaptation) with significant neural overlap between the two
involving activation in the right DLPFC (Seidler et al., 2012).
CSL related to working memory in rodents has not, however,
been shown to have an effect on the exploratory tendencies or
other non-specific behavioral consequences of exposure to envi-
ronments outside of the home cage (Light et al., 2010). Beyond
the impact of training on CSL, improvement of working mem-
ory has been found as an immediate and latent effect of cathodal
and anodal transcranial direct current brain stimulation (tDCS)
when paired with training in humans (Dockery et al., 2009).
The benefits of tDCS on spatial working memory and CSL in
a rat model have furthermore been demonstrated in the place
avoidance alternation task (Dockery et al., 2011). Interestingly,
recent evidence suggests that anodal tDCS results in a reduction of
GABA concentration, while cathodal stimulation decreases glu-
tamate concentrations, in correlation with reduced GABA levels,
as measured by magnetic resonance spectroscopy in the sensori-
motor cortex (Stagg et al., 2009). It has been proposed that the
cumulative benefits on working memory may result from home-
ostatic effects of tDCS through its interaction with mediators of
neuronal function and plasticity in rats and humans (Dockery,
2013).
Activation of N-Methyl-D-aspartate (NMDA) receptors by
glutamate is critical for long-term potentiation (LTP) and long
term depression (LTD). They comprise a form of experience–
dependent change in synaptic efficacy which is accepted as a
cellular analog of learning, long-term memory storage (Lynch,
2004; Pastalkova et al., 2006), working memory and cognitive
function (Timofeeva and Levin, 2011; Wang et al., 2013). Over
expression of glutamate excitation involves increased intracellu-
lar Ca2+ and Na+ ions which generate excitotoxic effects. These
effects are responsible for triggering neurodegeneration in many
neurological diseases and disorders such as: AD, stroke, status
epilepticus and head trauma. Impairment of working memory is
a symptom of cognitive dysfunction which occurs with ageing,
brain trauma, and neuropsychiatric diseases such as depression,
Alzheimer’s disease (AD) or schizophrenia (Elvevåg et al., 2000).
By studying the effect of NMDAR blockade on cognitive and
non-cognitive processes, the role of NMDA receptors in the hip-
pocampus, involved in working memory encoding and retrieval
(Yoshihara and Ichitani, 2004), and their role in the prefrontal
cortex, subserving persistent neuronal firing in the absence of
sensory stimulation (Wang et al., 2013), can be further eluci-
dated. Loss of the NMDA receptor NR1 subunit in the granule
cells of the dentate gyrus impaired spatial memory (Niewoehner
et al., 2007), and NMDA receptor deletion has been shown to
both restrict CA3 pyramidal cells (Nakazawa et al., 2003) and
affect spatial working memory. Moreover, blockade of NMDARs
in the different subregions of the hippocampus has been found to
affect different stages of spatial workingmemory (Lee and Kesner,
2002).
The NMDAR is a complex comprised of several heterogeneous
subunits, which contains binding sites for the different modes
of action of non-competitive antagonists such as (+)MK-801
(commercial name: Dizocilpine) or memantine (Paoletti et al.,
2013). MK-801 acts without subunit selectivity and, with a long
dwell-time in the ion channel, results in a slow off-rate and high
affinity to NMDAR (Wong et al., 1986; Chen and Lipton, 2006).
Memantine acts via a shorter dwell-time (faster off-rate), lower
affinity and higher voltage dependence (Parsons et al., 1995; Chen
and Lipton, 2006). It blocks excessive NMDA receptor activity
without impairing normal activity, which is a feature of uncom-
petitive antagonists. Blockade of NMDA receptors by memantine
and MK-801 has been proposed as a therapeutic intervention for
neuroprotection in neurodegenerative diseases such as Alzheimer
and Parkinson’s Disease or stroke (Zajaczkowski et al., 1996;
Danysz et al., 1997). However, the different properties of the two
agents in regard to NMDARs influence the differential effects on
cognitive and non-cognitive behavior.
NMDAR activity relates to normal and abnormal function of
the nervous system via their excitatory activity (Chen and Lipton,
2006), whereby the levels of transmission represent a continuum
with polarities between excessive and inadequate transmission.
The critical aspect then in achieving therapeutic efficacy to ame-
liorate neurological diseases and psychiatric disorders, is through
the capacity to register the current state of the NMDAR activ-
ity on this continuum and apply appropriate dosing of NMDAR
antagonism to achieve health and reinstate proper function. MK-
801 application in animal studies was found to impair food
consumption, and disturb mobility (locomotor activity) and psy-
chogenic activity (stereotypic activity and ataxia) (Mondadori
et al., 1989; Whishaw and Auer, 1989), in addition to psychotic
dysfunction in rats (Manahan-Vaughan et al., 2008). In healthy
humans, MK-801 administration has been associated with hal-
lucinations, delusions and affective blunting. Memantine in high
doses has also been found to disturb motor function and sponta-
neous responses such as rearing (Creeley et al., 2006). However, in
contrast toMK-801, formemantine the distinction between doses
which produced undesirable side effects and those which elicit
promising therapeutic effects are clearly distinguishable (Morè
et al., 2008). A pharmacological study showed that injection of
5mg/kg of memantine resulted in plasma concentrations in a
therapeutic range (about 1.0 umol/l), which is safe and does not
cause learning andmemory impairment. Whereas higher doses of
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memantine (10mg/kg) were found to produce plasma level con-
centrations that were fivefold higher than those which mediated
therapeutic effects in patients requiring treatment (Zoladz et al.,
2006).
The effects of MK-801 and memantine have been studied in
relation to cognitive function in animal models of long- and
short-termmemory, but have rarely been tested in working mem-
ory paradigms. The effects on memory have been shown to
be dose- and time-dependent. When applied 30min before the
experiment both memantine (in 0.5 or 1.0mg/kg doses) and
MK-801 (in 0.025 or 0.05mg/kg doses) preserved intact work-
ing memory performance in a delayed match–to–position task
(Smith et al., 2011). Whereas memantine in 5mg/kg or MK-
801 in801 in 0.1mg/kg doses impaired working memory in the
same test. The low and high doses of MK-801 (0.25, 0.5, 1.0,
4.0mg/kg) made working memory worse in the water maze test
shortly after injections (from 3h to 1 day post-treatment), but
not on the third or the fourth post-treatment day (Whishaw and
Auer, 1989). In the radial maze, working memory was intact in
rats with high doses of memantine (20mg/kg per day) and MK-
801 (0.312mg/kg per day) applied as a chronic infusion during
the experiment (Zajaczkowski et al., 1996) or post-administration
of a 5mg/kg dose of MK-801 and high doses of memantine (20
and 40mg/kg) with a long delay (8 days) (Zajaczkowski et al.,
2000). Also acute application of moderate doses of memantine
(2.5, 5.0, 10.0mg/kg) preserved short-term memory in the radial
water maze test (Zoladz et al., 2006). After a high dose of meman-
tine (20mg/kg) a slight improvement in working memory was
observed at the onset of training in the radial maze (Zajaczkowski
et al., 2000).
The experimental results collectively suggest palliative effects
of memantine in low doses with mixed results for MK-801. As
a consequence of such experimental results, memantine received
authorization as a treatment for AD in 2002 in the EU and in
2003 in the USA (Parsons et al., 2007). In contrast, MK-801
dose-dependently inducedmobility disturbances and long-lasting
spatial memory impairment (Zajaczkowski et al., 1996), which
mimics symptoms of schizophrenia. Therefore, application of
MK-801 has been proposed as an animal model of schizophrenia
using the active allothetic place avoidance method (Vales et al.,
2010).
In active place avoidance tasks, a freely walking rat must
remember and avoid an unmarked place on an elevated arena
where foot-shocks are administered. When associated with a
rotating arena in light, this place, or “to-be-avoided sector,” is
oriented according to room frame coordinates in which place
avoidance demands segregation of relevant extramaze room stim-
uli from irrelevant intramaze arena stimuli. To achieve accurate
memory performance in the active place avoidance task, segrega-
tion of relevant from irrelevant arena frame stimuli is required,
a process which engages cognitive coordination (Wesierska et al.,
2005). The inability to segregate stimuli has been proposed as a
disturbance in cognitive coordination which is found in patients
with schizophrenia (Phillips and Silverstein, 2003).
In order to specifically test working memory and CSL, a vari-
ant of the active place avoidance, the Allothetic Place Avoidance
Alternation Task (APAAT), has been developed (Dockery and
Wesierska, 2010). Due to the alternation aspect of the APAAT task,
in which the to-be-avoided sector is alternated daily, new infor-
mation is needed for each session in order for rats to perform
place avoidance correctly. As training progresses, simultaneously
the memory load also increases, as rats are obliged to contin-
ually update the location of the to be-avoided sector since its
location changes for each day. To date a dose-response rela-
tionship concerning the effects of NMDAR blockade on APAAT
performance has not been established. By determining the dose-
response curve in this task, the possible remedial effects of the
relevant drugs could be clarified. The aim of the presented study
was to compare the cognitive and non-cognitive processes during,
immediately after, and following a long delay post-drug admin-
istration of a range of doses of memantine and MK-801 in this
task. Thereby, the APAAT allowed for simultaneous examination
of spatial working memory capacity and the efficiency of CSL, in
addition to locomotor activity as a non-cognitive process. Such
comparisons have never been previously conducted.
MATERIALS AND METHODS
ANIMALS
Eighty-one naïve adult (3.5-month-old) male Long Evans rats,
weighing 270–360 g, were obtained from the breeding colony of
the Nencki Institute of Experimental Biology, Polish Academy of
Science, Warsaw, Poland. They were accommodated in transpar-
ent plastic home cages, four per cage, under standard conditions
(a constant temperature of 22◦C, 12:12 light/dark cycle, humidity
at 23%). Water and food were available in the cages ad-libitum.
The animals were handled for four days prior to the onset of
the experiment. All manipulations were done according to the
European Community Directive for the ethical use of experimen-
tal animals and the Polish Communities Council for the care and
use of laboratory animals.
DRUG TREATMENT
Memantine—(3, 5-Dimethyl-1-adamantanamine hydrochloride,
3,5-Dimethylamantadine hydrochloride; Sigma Aldrich) was dis-
solved in saline (5, 10, 20mg/ml) and injected intraperitoneally
(5, 10, 20mg/kg b.w.). (+)MK-801–((5S,10R)-(+)-5-Methyl-
10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
hydrogen maleate, Dizocilpine hydrogen maleate; Sigma
Aldrich) was dissolved in saline solution (0.1, 0.2, 0.3mg/ml)
and injected intraperitoneally (0.1, 0.2, 0.3mg/kg b.w.). For
both drug treatments, the animals received the same volume of
liquid per kg of body weight which was applied 30min before the
training sessions on Days 1, 2, and 3.
APPARATUS
The active allothetic place avoidance apparatus was previously
described in detail (Wesierska et al., 2009). Briefly, the appara-
tus consisted of an 80-cm-diameter, rotating (1 rpm) platform or
“arena” made of aluminum. It was elevated (80 cm), and located
in a room with dim light and explicit visual landmarks (pictures,
lamp, furniture). Rats wore a latex harness on their back upon
which an infrared light-emitting diode (LED) was fixed. The sec-
ond LED was attached to the periphery of the arena. The infrared
TV camera was connected to a computer system which allowed
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for monitoring the position of the rat. Rats were pierced between
the shoulders with a subcutaneous connector (surgical needle)
which provided an anchor for a mini-alligator clip that was con-
nected by a cable to the shock box. Every time the rat entered the
to-be-avoided sector (60◦) a mild, constant current foot-shock
was delivered through the connector placed on the rat’s back.
The shock was repeated every 1.5 s until the rat escaped from the
shock sector. The data were collected and analyzed by the place
avoidance system (Bio-Signal Group, Brooklyn, New York).
EXPERIMENTAL GROUPS
Rats (n = 81) were randomly divided into eight groups. The
Control group of rats consisted of intact animals (n = 12) and
rats treated with saline (n = 11; 1ml/kg b.w.). The memantine
group was divided into three subgroups according to the dosage: a
low (MemL) 5mg/kg (n = 12), medium (MemM) 10mg/kg (n =
12) and high (MemH) 20mg/kg (n = 10) dosage group. Likewise,
the dizocilpine ((+)-MK-801) group of rats was divided into
three subgroups: a low (MK-801L) 0.1mg/kg (n = 8), medium
(MK-801M) 0.2mg/kg (n = 8) and high (MK-801H) 0.3mg/kg
(n = 8) dosage group (Table 1).
BEHAVIORAL PROCEDURES
The experiment was divided into two stages. The first stage con-
sisted of Days 1, 2, and 3 (D1, D2, D3), during which rats were
injected with drugs and underwent training and testing sessions
on the rotating arena. The second stage consisted of a single
session, Day 21 (D21), which served as a follow-up to test the
long-term influence of prior memantine and MK-801 injections
paired with training on performance in the APAAT. On D21
rats were not injected before the behavioral session, however, the
behavioral conditions were the same as for the first stage.
The experiment started on Day 0 which served as the habi-
tation during which the rats were placed on the rotating arena
for 5min without an active shock sector. The next days (D1, D2,
and D3) were training days during which the rats were injected
intraperitoneally 30min before the avoidance training began.
Each behavioral session began with habituation (ha) on the rotat-
ing arena with an inactive shock sector. After 5min of habituation
the to-be-avoided sector was activated. The rats which were able
to avoid the sector consistently for at least 90 s. completed the
two training intervals after 10min (5min for tr1 and 5min for
tr2) and were removed from the arena. If a rat did not reach
this criterion before the end of the 10min, they underwent an
additional 5min of training. Those rats then underwent a 5min
delay period in a cage in an adjacent room. Afterwards, they
were returned to the rotating arena for the 5min retrieval test
(ts). During the test the original shock sector was inactivated.
The to-be-avoided sector was defined by room frame coordi-
nates and was changed each day according to the following order:
D1–Northwest, D2–Northeast, D3–Southwest, D21–Southeast.
MEASURES
The independent variables taken to describe cognitive working
memory processes included the number of entrances into the
shock sector (ENTR), the maximum time spent avoiding the
shock sector (s) (Tmax) and the number of shocks per entrance
(SH/ENTR). For habituation and the retrieval test, the shock
was inactivated, however, the program still registered undelivered
number of shocks related to the rat’s presence in the to-be-
avoided sector. This provided an index of “untrained behavior.”
During training, a high SH/ENTR ratio expresses poor CSL. Non-
cognitive functions were assessed by locomotor activity by the
total path length (distance) (m) and linearity (Lin). The latter
was calculated as the average ratio of linear distance during each
two-second time bin divided by the sum of the path distance
determined by each 20ms epoch.
DATA ANALYSIS
Based on the above measures for D1–3, analysis of the across
session effects on performance was performed by a three-way
ANOVA (group (MemL, MemM, MemH, MK-801L, MK-801M,
MK-801H, CONTR) × day (D1, D2, D3) × condition (ha, tr1,
tr2, ts): 7 × 3 × 4; with repeated measures on the last factors)
followed by a Tukey HSD multiple comparison post-hoc test. On
D21, a two-way ANOVA (group (MemL, MemM, MemH, MK-
801L, MK-801M, MK-801H, CONTR) x condition (ha, tr1, tr2,
ts): 7 × 4; with repeated measures on the last two factors) was
performed with a Tukey HSD test for multiple comparisons.
Significance was accepted at a level of P < 0.05. The statistical
analysis was performed with STATISTICA 7.1. Group averages
and ±s.e.m. values are reported.
RESULTS
DOSE-RELATED EFFECTS OF MEMANTINE AND MK-801
ADMINISTRATION ONWORKING MEMORY TRAINING (DAYS 1–3)
EVALUATED BY THE NUMBER OF ENTRANCES INTO AND MAXIMUM
TIME SPENT AVOIDING THE SHOCK SECTOR. HIGH DOSES OF BOTH
AGENTS IMPAIRED WORKING MEMORY, WHILE LOW DOSES HELPED
MAINTAIN OR EVEN IMPROVE (MEMANTINE) IT
Working memory performance expressed as the number of
entrances (ENTR) into the shock sector changed according to
the agents used and their doses [F(6, 74) = 29.068; P < 1 × 10−16;
MemH, MK-801H > CONTR, MK-801L, MK-801M, MemL,
MemM], across days [F(2, 148) = 5.42; P < 0.005; D1, D2 > D3]
and for the different conditions within a session [F(3, 222) =
74.70; P < 0.000001; tr2 < ts < tr1 < ha] (Figure 1A). Working
memory was worse (more entrances) after the high doses of
both agents (P < 0.0001). Rats performed better on D3 than
on D1, and D2 (P < 0.001). Although during the test condi-
tion rats had more entrances than during tr2, it was significantly
less than in tr1 and ha (P < 0.0008). The post-hoc evaluation of
the group by day interaction [F(12, 148) = 6.27; P < 6.7 × 10−8]
confirmed that rats from the MemL, MK-801L, and CONTR
groups showed a lower number of ENTR across the consecutive
days. Their performance was better (fewer entrances) than in the
rats with MemH on D2 and D3, and MK-801H on D1 and D2
(P < 0.001). The post-hoc test for the group by condition inter-
action [F(18, 222) = 3.26; P < 1.8 × 10−4] showed that avoidance
during tr2 was better than in the other conditions for the MemL,
MK-801L, and CONTR groups (P < 0.01). In contrast, the num-
ber of ENTR for MemH and MK-801H was at a similar level for
all the session conditions and was worse (more entrances) than
in the other groups (P < 0.001). On D3 the number of ENTR
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Table 1 | Description of experimental groups.
Group Memantine (+)MK-801(Dizocilpine) Control
Dosage
MemL MemM MemH MK-801L MK-801M MK-801H Saline
n = 11
(1ml/kg)
Intact
n = 12
 n = 23
mg/kg b.w. 5 10 20 0.1 0.2 0.3
#Rat’s per group n = 12 n = 12 n = 10 n = 8 n = 8 n = 8
FIGURE 1 | The high dose of memantine and MK-801 (MemH and
MK-801H, respectively), in contrast to the low doses, impaired
working memory performance in the allothetic place avoidance
alternation task as shown by a high number of entrances for D1–3 (A).
This effect was absent for the long-term follow-up when no drug was
administered (D21), however, rats previously treated with MemH
performed worse than those previously treated with MK-801H (B). The
values are presented as the average number of entrances (±s.e.m.) for
groups, across all days and for all conditions. The values are presented as
the grand average (±s.e.m.) according to group, day and condition.
Memantine doses: low MemL–5mg/kg, medium MemM–10mg/kg and
high MemH–20mg/kg. (+)MK-801 doses: low MK-801L–0.1mg/kg, medium
MK-801M–0.2mg/kg and high MK-801H–0.3mg/kg. The shaded columns
represent the conditions during which shock was activated.
during tr2 was lower than for the other session conditions for all
days as shown by a post-hoc for the day by condition interaction
[F(6, 444) = 10.69; P < 4 × 10−10; post-hoc test; P < 0.0004].
In the APAAT, the maximum time avoided (Tmax) is
used to represent working memory performance. It dif-
fered depending on the group [F(6, 74) = 18.70; P < 4 × 10−12;
MemL > CONTR, MemH,MK-801H, MK-801M] and condition
[F(3, 222) = 83.39; P < 0.00000; tr2 > ts > tr1 > ha], whereas
there was no significant effect of days (Figure 2A). The post-hoc
test confirmed that rats treated with MemL avoided better (a
higher Tmax) than the CONTR (P < 0.02), MemH, MK-801M,
and MK-801H (P < 0.001; P < 0.0001) groups. No differences
were found between the MemL and MK-801L, or between the
MK-801L and control rats. The rats treated with MemH or MK-
801H performed worse than the rats from the other groups. For
condition, the shock sector was avoided with a longer Tmax dur-
ing tr2 than during the other conditions (post-hoc; P < 0.002).
Although the Tmax during the retrieval test (shock inactivated)
was shorter than during tr2 (post-hoc test; P < 0.0008), it was
longer than the Tmax during tr1 and ha (post-hoc test; P <
7 × 10−6). The post-hoc for the group by condition interaction
[F(18, 222) = 4.86; P < 3 × 10−8] showed that the Tmax dur-
ing tr2 was shorter for the control than for MemL (P < 0.02),
MemH and MK-801H (P < 0.0001) groups, and similar as that
for theMK-801L,MK-801M, andMemMgroups. The rats treated
by high memantine or MK-801 presented a low Tmax for all
conditions. The post-hoc for the day by condition interaction
[F(6, 444) = 5.59; P < 1 × 10−4; P < 0.02] showed that the Tmax
was similar for tr2 across all days. The Tmax was higher for tr2
than for tr1, ha (D1-3) and ts (except for on D1).
DOSE-RELATED EFFECTS OF MEMANTINE AND MK-801
ADMINISTRATION ON COGNITIVE SKILL LEARNING (DAYS 1–3)
EVALUATED AS THE SHOCKS PER ENTRANCE RATIO (SH/ENTR). RAPID
ACQUISITION OF COGNITIVE SKILL LEARNING (WITHIN THE FIRST
SESSION) OCCURRED ANDWAS MAINTAINED OVER THE LONG-TERM
(BETWEEN SESSIONS) AFTER TREATMENT WITH LOW DOSAGES OF
BOTH OF THE NMDAR ANTAGONISTS
CSL was expressed as the shock per entrances ratio (SH/ENTR).
It was dependent on condition [F(3, 222) = 77.48; P < 0.0000)(ha
> tr1, ts > tr2], but not day [F(2, 148) = 0.83; P = 0.43]
(Figure 3A). Although the main effect of treatment [F(6, 74) =
2.91; P < 0.013] was significant, the post-hoc did not show a sig-
nificant difference between groups. The SH/ENTR ratio was the
highest during habituation (P < 6 × 10−5) and the lowest during
tr2 (P < 7 × 10−4). The post-hoc test for the group by day inter-
action [F(12, 148) = 2.22; P < 0.013] showed that the SH/ENTR
ratio was similar for all groups on D1 and D2. On D3 the ratio for
MemH was lower than that for MK-801M only (P < 0.001).
The post-hoc evaluation of the group by condition interac-
tion [F(18, 222) = 5.35; P < 2 × 10−9; P < 0.01] confirmed that
during tr1 the SH/ENTR ratio was lower than during ha for the
CONTR, MK-801L and MemL groups (P < 0.01), whereas rats
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FIGURE 2 | The benefit of low-dose memantine on working memory
performance was evidenced by a longer maximum time avoided
(Tmax) in comparison to the control, MemH and MK-801H rats
(P < 0.02; P < 0.0001; P < 0.0001, respectively) (A). Without any drug
administration (D21) working memory performance was similar for all
groups, but post-treatment MemH rats were worse than post-MK-801H
(B). The values are presented as the average Tmax (±s.e.m.) for groups
across days and for all conditions. Other figure elements are the same as in
Figure 1.
treated with middle or high doses of MK-801 and memantine
presented similar ratios during ha and tr1. Rats from the high
MK-801 and memantine groups presented similar ratios across
all conditions. The post-hoc evaluation for the day by condi-
tion interaction [F(6, 444) = 6.27; P < 2 × 10−5] showed that the
ratios for ha and tr1 on D1 were similar, whereas on the next days
the ratio for tr1 decreased compared to ha (P < 0.0003).
DOSE-RELATED EFFECTS OF MEMANTINE AND MK-801
ADMINISTRATION ON NON-COGNITIVE FUNCTIONS EXPRESSED BY
THE DISTANCE WALKED BY RATS AND THE LINEARITY
(STRAIGHTNESS), OF THE RAT’S PATH. THE HIGH DOSE OF MK-801
WAS ASSOCIATED WITH HYPERACTIVITY, BUT DID NOT AFFECT
LINEARITY
The distance walked by rats was dependent on treatment and con-
dition as confirmed by a significant effect of group [F(6, 72) =
21.01; P < 4 × 10−13; MK-801H > all other groups] and con-
dition [F(3, 216) = 4.69; P < 0.003; tr2 > ha, tr1, ts], whereas
an effect of day was not significant [F(2, 144) = 2.34; P = 0.099]
(Figure 4A). The post-hoc test for groups showed that the MK-
801H rats walked more than the other rats (P < 0.0001; P < 0.05
for MemH). The rats from the CONTR group walked a shorter
FIGURE 3 | Cognitive skill learning in the allothetic place avoidance
alternation task was calculated as the ratio of shocks per entrances
(SH/ENTR) into the shock sector which developed according to day
and condition (A). On D1 the ratios for ha and tr1 were similar, whereas
for D2 and D3 it decreased for tr1 in comparison to ha. Without any drug
administration (D21), all rats presented similar skill levels in which
performance was dependent on condition (B). The values are presented as
the grand average (±s.e.m.) according to group, day and condition. Other
figure elements are the same as in Figure 1.
distance than the rats treated by high doses of memantine and
MK-801. The post-hoc test for condition confirmed a longer dis-
tance for tr2 than for the other conditions (P < 0.004). Rats
presented a similar distance during tr1, ha, and ts. The post-hoc
evaluation of the group by day interaction [F(12, 144) = 8.81; P <
1.7 × 10−11] confirmed that theMK-801H rats walked a similarly
long distance every day, which was similar to that of the MemH
rats on D3 (P < 1.7 × 10−5). Rats treated with MK-801H walked
a long distance for all conditions [group by condition interaction
F(18, 216) = 5.08; P < 1.2 × 10−8; P < 0.001]. The post-hoc eval-
uation of the day by condition interaction [F(6, 432) = 7.19; P <
2.5 × 10−6] confirmed a shorter path during habituation on D2
and D3 than for the other conditions (P < 0.01). No differences
were found between tr1 and tr2 for all days.
Linearity, which represents the straightness of a rat’s path in
the arena according to a 20ms sampling rate, changed dependent
on treatment [F(6, 72) = 16.22; P < 10 × 10−10; Control, low and
MK-801M and MemM < MK-801H and MemH] and condi-
tion [F(3, 216) = 2.78; P < 0.04; tr1 > ha] (Figure 5A). Rats from
the high MK-801 and memantine groups walked straighter than
the other rats (a high linearity value) (P < 0.002). Rats walked
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FIGURE 4 | Non-cognitive function was represented by the activity
levels measured by the distance [m] walked in the allothetic place
avoidance alternation task. After the high dose of MK-801 (MK-801H) the
activity level was high across all days (D1-3), while it was only high for D3
following the high memantine dose (MemH) (A). Without any drug
administration (Day 21), hyperlocomotion in MK-801H rats post-treatment
ceased and locomotion returned to a similar level as in other post-treated
rats (B). The values are presented as the grand average (±s.e.m.) according
to group, day and condition. Other figure elements are the same as in
Figure 1.
straighter during tr1 than during ha and ts (P < 0.03), with no
differences found between tr2 and the other conditions. The post-
hoc evaluation of the group by day interaction [F(12, 144) = 5.54;
P < 9 × 10−7] showed that MK-801H rats presented a similar
linearity value across days, which was similar to MemH except for
on D1, but was higher than in the other groups of rats (post-hoc
test; P < 0.001). The post-hoc evaluation of the group by condi-
tion interaction [F(18, 216) = 1.91; P < 0.016] confirmed that the
MK-801H and MemH rats had a similar linearity across condi-
tions, which was higher than in the other groups independent
of condition (P < 0.0001). The linearity values during ha and
tr1on D1 and D2 were similar, which were lower than during tr1,
tr2, and ts on D3 (post-hoc; P < 0.01) for the day by condition
interaction [F(6, 432) = 4.941; P < 6 × 10−4].
LONG-TERM EFFECTS (D21) ON WORKING MEMORY WITHOUT DRUG
ADMINISTRATION
Proper functioning of working memory post-drug administra-
tion and early training (D21) was evidenced by a low number of
entrances with a long maximum time avoided and via demon-
stration of the effective skill to avoid the new to-be-avoided
sector.
FIGURE 5 | The linearity of the path on the arena in the allothetic place
avoidance task was straighter for the MK-801H rats across days (D1–3),
and on D2 and D3 for the MemH rats (A). On D21, the linearity was
dependent on condition (B).The values are presented as the grand average
(±s.e.m.) according to group, day and condition for rats treated with
different doses of memantine or MK-801. Other figure elements are the
same as in Figure 1.
Working memory performance in control rats and rats after
memantine or MK-801 administration was assessed on D21
according to the number of entrances. A significant effect was
confirmed for group [F(6, 74) = 3.98; P < 0.002] and condition
[F(3, 222) = 34.501; P < 2 × 10−18] (Figure 1B). The post-hoc for
group confirmed that MK-801H rats (no drug administered) per-
formed better than MemH rats (P < 0.002), but the difference
between the control and other treatment groups was not signifi-
cant. The number of ENTR during tr2 was lower than during the
other conditions (ha > tr2 < tr1, ts; P < 0.001).
The maximum time avoided showed significant effects
of group [F(6, 74) = 6.37; P < 1, 9 × 10−4] and condition
[F(3, 222) = 37.47; P < 1, 2 × 10−18], and a group by condition
interaction [F(18, 222) = 1.80; P < 0.03] (Figure 2B). Although
the MK-801H rats presented a longer maximum avoidance time
than the MK-801L, MK-801M and MemH rats (P < 0.04), it was
similar to that for the control rats. The Tmax was longer during
tr2 than during the tr1, ts and ha conditions (P < 0.0001), but
no difference was found between tr1 and ts. The post-hoc test for
the group by condition interaction confirmed that during tr2 the
rats from the MK-801H group had a longer Tmax than the rats
from the MK-801L, MemH and CONTR groups (P < 0.03). The
MemH rats presented a shorter Tmax across all conditions.
The SH/ENTR ratio on D21 showed significant effects for
condition [F(3, 222) = 74.04; P < 0.00001] and for the group by
condition interaction [F(18, 222) = 2.06; P < 0.008]. There was a
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low ratio during tr2 and a high ratio during the ts compared to
during tr1 and ha (post-hoc test; P < 0.0002). The ratio during tr1
was lower than during ha and the ts (post-hoc test; P < 1 × 10−7).
The post-hoc test for the interaction showed similar SH/ENTR
values during tr2 across groups (Figure 3B).
LONG-TERM EFFECTS (D21) ON NON-COGNITIVE FUNCTIONWITHOUT
DRUG ADMINISTRATION
On D21 the locomotor activity was dependent on condition
[F(3, 219) = 9.66; P < 5 × 10−5] and showed a group by condi-
tion interaction [F(18, 219) = 2.41; P < 0.0015] (Figure 4B). All
rats walked more during habituation and tr2 than during tr1 and
ts (P < 0.0001). The post-hoc for the group by condition interac-
tion confirmed that during habituation rats previously treated by
MemMwalked a longer distance than the other rats, except for the
rats previously treated withMemH (P < 0.001). Furthermore, on
D21 linearity was dependent on condition [F(3, 216) = 3.62; P <
0.01] (Figure 5B). All rats walked a straighter path (higher linear-
ity values) during tr2 than the ts (P < 0.04), while the values were
equivalent during tr1 and the ts.
DISCUSSION
The presented study focused on comparisons of on-going cogni-
tive and non-cognitive processes in the spatial working memory
test, the APAAT task, using a wide range of doses of memantine
and MK-801. We have shown that a low dose of memantine was
associated with a short-lasting improvement in spatial working
memory in comparison to the controls. Such an effect was not
observed after application of a low dose of MK-801. However,
at the low dose no differences in working memory were found
between the two drug groups. CSL developed during the first
training interval for groups with low doses of the agents. In
contrast, high doses of the agents impaired workingmemory, neg-
atively affected CSL and involved hyperactivity. In the same rats
the after-effects of both agents were studied on D21 in the APAAT
without drug application. Although all rats performed well in the
working memory task and both maintained and updated their
skill appropriately according to the novel sector location and the
established session conditions, the MK-801H group avoided bet-
ter during training 2 than the control, MK-801L and MemH
groups. In contrast, the non-cognitive indices of locomotor activ-
ity (path length and linearity) showed dependence on the training
conditions only.
In our working memory variant of the place avoidance test, in
order to achieve accurate daily place avoidance, both stimuli seg-
regation and short-term memory was required. The latter being
necessary for the formation of new representations of the novel
location of the shock sector. Memory acquisition occurred dur-
ing tr1 and tr2, when the shock was presented, and was tested
during the retrieval test (shock inactivated), which started 5min
after the end of tr2. With exposure to these conditions, intact rats
improved place avoidance throughout the training sessions, when
shocks were presented, and they generally continued to avoid even
when the shock was inactivated during the retrieval test (Dockery
andWesierska, 2010). This variant differed from a previously pre-
sented working memory variant of place avoidance, wherein the
location of the shock sector was alternated from day to day but
the daily session did not include a habituation condition (5min
ha before avoidance training in our procedure) and consisted of
only a single training interval (Cimadevilla et al., 2000). In such
trials, comparison of working memory and CSL within a session
was not possible as within a session the two abilities were mutu-
ally exclusive. This is due to the fact that in non-alternative variant
of place avoidance the rats are always confronted with the same
shock-sector location, meaning that they only have to learn the
place it occurs in the room-frame coordinates itself. It does not
necessitate, however, the application of the rule of how to avoid
a to-be-a-frame (in any location), as is required in the alternative
variant.
When taking into consideration the three components which
comprise the working memory system in animals: goal mainte-
nance, interference control, and memory capacity (Dudchenko
et al., 2012), the working memory variant of active place avoid-
ance used in this study seems to be a very useful tool to control
the relation between these components. Furthermore, it offers
the possibility to test non-cognitive behavior in intact and phar-
macologically treated animals. To break down the components
according to the APAA task conditions, the place avoidance dur-
ing tr1, tr2 can be related to goal maintenance, as the rats must
use the representation of the shock sector in order to avoid, for
a long period of time, entering the actual place where shocks
could be delivered. Moreover, interference control also relates to
formation of a new representation, which occurs in the conse-
quent session (e.g., from D1 to D2). Thus, interference control
would be responsible for proper avoidance in each consecutive
session. Better place avoidance performance in tr2 compared to
tr1 depends on more effective on-going memory and, in this way,
could be related to memory capacity. All components, mainte-
nance, interference control and memory capacity were impaired
under NMDARs blockade by high doses, in contrast to low and
middle doses of the antagonists, memantine andMK-801. Hence,
although the APAAT currently has no complementary human set-
up, it has been shown to be a useful tool to study the relation
between components of working memory and the underlying
mechanisms which control this system.
Working or short-term memory has been previously moni-
tored by other authors/research groups in several animal models
of spatial working memory under different doses of memantine
or MK-801 with the primary aim to utilize these NMDAR antag-
onists as therapeutic treatment against excitotoxicity in neurode-
generative diseases (see Ref. in Introduction). In the presented
study, acute application of memantine in a dose of 5mg/kg pre-
served or even facilitated spatial working memory functioning
in the APAAT. Similar to the control rats, this therapeutic dose
resulted in a low number of entrances during the training and
test conditions and also involved short-lasting enhancement of
memory in tr 2, which manifested as a significantly longer max-
imum time avoided. For comparisons low doses of memantine
(0.3; 0.56mg/kg), but not a higher dose (1.0mg/kg), enhanced
spatial memory after a 18 h delay in the radial maze task, whereas
higher doses (3 and 10mg/kg) totally abolished choice accuracy in
the same test (Wise and Lichtman, 2007). In contrast, enhance-
ment of long-term memory was found after a 24 h delay in the
radial arm water maze for the 5 and 7.5mg/kg, but not the 2.5
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and 3.75mg/kg doses. In the same test the same doses had no
effect on short–term memory acquisition and retention which
was tested after a 15min delay (Zoladz et al., 2006). Daily con-
tinuous infusion of 20mg/kg memantine by minipumps did not
impair working memory in the radial maze (Zajaczkowski et al.,
1996). Contradictory to this data, acute memantine application
at a high dose (20mg/kg) negatively affected working memory
in our experimental conditions, which manifested as a higher
number of entrances with a short maximum time avoided across
days.
Discrepancy in the obtained results, as reflected by the data
reported here from various behavioral procedures (dry vs. water
maze; appetitive vs. aversive conditions), are the result of differ-
ences in the memantine plasma concentration during the exper-
imental session, which are dependent on the dose and means of
administration (Zoladz et al., 2006).
In view of the similarities and differences between meman-
tine and MK-801, an effect of the latter drug was also studied
in terms of memory functioning. Unlike low dose memantine,
the low dose of MK-801 (0.1mg/kg) had no effect on working
memory enhancement. However, alike memantine, the high dose
of MK-801 (0.3 mg/kg) abolished working memory across the
training and test conditions. These results are consistent with
recently published data from the Stuchlik Laboratory (Zemanova
et al., 2013) which revealed memory impairment in the APAAT
after MK-801 in doses of 0.12 and 0.15mg/kg in naive rats but
not in pre-trained rats. Moreover, in the active place avoidance
task, MK-801 in the 0.2, but not the 0.15mg/kg impaired reacqui-
sition of avoidance in the training conditions, whereas both doses
impaired place avoidance performance in a new environment
(Stuchlík and Vales, 2005). Our experiment was conducted on
naive rats in the same environment with doses lower (0.1mg/kg)
and higher (0.3mg/kg) than those in the previous studies which
further supports the reliability of our results. Effect of MK-801
on working memory depending on the dose also in other tests
on spatial memory. In the radial maze task working memory was
preserved with the 0.05, 0.01,mg/kg 0.08 and 0.1mg/kg doses
and impaired with 0.12, 0.15 or 0.2mg/kg of MK-801 (Wozniak
et al., 1990; White and Best, 1998; Kretschmer and Fink, 1999).
However, acquisition of workingmemory itself and in a new envi-
ronment in the radial maze was impaired after a 0.0625mg/kg
dose of MK-801 (Shapiro and O’Connor, 1992). Chronic appli-
cation of MK-801 at a 0.312mg/kg daily dose by minipumps not
impaired working memory in the radial maze test (Zajaczkowski
et al., 1996). Contrary to dry radial maze test a single applica-
tion of MK-801 at the 0.25, 0.5, 2, and 4mg/kg doses impaired
spatial working memory in the water maze on day 1 but this
effect disappeared on day 4 (Whishaw and Auer, 1989). It has
also been shown that the effect of different doses of MK-801 on
spatial memory performance and locomotor activity depend on
the experimental procedure, e.g., the water maze test seems to be
more sensitive to MK-801 than the dry open field test (Wegener
et al., 2011).
To summarize,MK-801 in low doses (0.05mg/kg, 0.08mg/kg),
was found to have no effect on working memory in naive rats
(Wozniak et al., 1990; Kretschmer and Fink, 1999), whereas
pre-training in the working memory task preserved memory
function even with the higher dose of MK-801 (0.12 or
0.15mg/kg) (Zemanova et al., 2013). Thus, taking into account
the cited literature, we believe that the 0.1mg/kg dose of (+)MK-
801 is sufficiently low, and that lowering it would likely produce
negligible effects on working memory in our APAAT.
The shocks/entrance ratio was a useful tool to measure CSL,
by which a high ratio expressed poor learning. During habitua-
tion, when shock was never applied, the SH/ENTR ratio expresses
a “dummy” ratio. Here it was at a similarly high level for all rats,
thus confirming that drugs application and the experimental con-
ditions, such as the arena rotation, which was the same for all rats,
did not change the rats’ spontaneous activity. On D1 the value
of the SH/ENTR ratio in all groups was similar for ha and tr1.
On this day the task rules were acquired. For D2-3 in all groups,
except the high dose groups, the SH/ENTR ratio was lower dur-
ing tr2 than during tr1 and ha. It means that the rats with low
and mild doses of both drugs successfully acquired the task rules.
However, on D2-3, it was only for the rats under high doses of
both agents that the ratio during tr1 and tr2 was similar with
no improvement. That means that high doses of those agents
suppressed CSL.
This is in concert with proper performance of working mem-
ory and flexible cognitive skill acquisition after low doses of the
agents, and consequently memory impairment and disturbed
CSL after the high doses related to the within session condi-
tions and an across session learning effect. In spite of a high
number of entrances after high doses of memantine and MK-
801, the SH/ENTR ratio was at a similar level across session
conditions which was similar to other groups (a non-significant
group effect). This suggests that high doses of both agents did
not disturb the ability to quickly recognize the shock sector and
minimize the shocks by escaping, thereby reducing the total num-
ber of shocks obtained per entrance even while the number of
entrances itself may have been high. Such an effective escape reac-
tion could be due to the higher locomotor activity after high
MK-801 across days and high memantine on D3. The differ-
ent results for working memory performance and CSL could
be explained by the heterogeneous nature of the components
which belong to the working memory system (Baddeley, 1992;
Dudchenko et al., 2000).
Measures of non-cognitive behavior were indexed by the activ-
ity characteristics: path length, and linearity. The path length
was longer with the high dose of MK-801 independent of day
and session condition. Contrary to the high dose of MK-801,
hyperactivity related to the high dose of memantine developed
throughout the training sessions. Independent of the doses of
both agents, all rats walked more during tr 2 than in the other
conditions. This result was in opposite to the findings pre-
sented by Zemanova et al. (2013), who showed that dose and
day but not condition affect the impact of MK-801 on total
distance. In training which focused on a stable shock sector
location on arena, locomotor activity also increased with the
0.2mg/kg, but not the 0.15 or 0.1mg/kg of MK-801 (Stuchlík
and Vales, 2005; Vales et al., 2010). In a swimming task the
locomotor activity was dose-dependent and time dependent, in
which it was impaired 3 h after MK-801 treatment in the doses:
0.25, 0.5, 1.0, 2.0, and 4.0mg/kg. This was relevant for four of
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the consecutive post–treatment days, but not for the fifth day
(Whishaw and Auer, 1989). Moreover, MK-801 in the 10mg/kg
dose resulted in catalepsy and doses higher than 10mg/kg were
found to be lethal (Whishaw and Auer, 1989). Memantine in a
high dose (20mg/kg) was reported to produce strong motor dis-
turbance in females rats, which was expressed as hypoactivity
10min after application and progressed to hyperactivity 90min
after drug administration (Creeley et al., 2006). The male rats in
our experiments also presented higher locomotor activity after
20mg/kg memantine but they were able to solve the APAAT
task.
Linearity is a unique measure of motor activity that accord-
ing to our knowledge is currently only calculated using the place
avoidance method. Here, a high linearity score (a straighter path)
was observed in high dose MK-801 group, which also showed a
significantly longer walk distance compared to other groups. Both
a long path length and high linearity were noted in rats from the
high dose memantine group on all days of training except the first
one.
The after-effect of memantine and MK-801 treatment on cog-
nitive and non-cognitive functions was tested with a new shock
sector location on D21, 18 days from the last exposure to the
agents. Because this period was over the half-life time for meman-
tine and MK-801 (Morè et al., 2008; Wegener et al., 2011) proper
place avoidance by rats from all groups was expected without
side effects. The results confirmed a lack of differences in work-
ing memory performance between the control rats and the rats
previously treated with either low or high doses of the agents.
This is in accordance with results in which a high dose of MK-
801 (5mg/kg) and memantine (20 or 40mg/kg) administered
intraperitoneally 8 days before training in the radial maze did
not affect acquisition of spatial working memory (Zajaczkowski
et al., 2000). However, detailed analysis of working memory per-
formance across session conditions shows that during tr2, rats
previously treated with the high MK-801 presented a lower num-
ber of entrances with a longer maximum time avoided than the
groups previously treated with the high memantine dose, low
MK-801 dose and the control rats. All rats on D21 showed a
similar level of performance for cognitive skill retention/learning.
The results primarily show an effect of the session condition in
which locomotor activity and linearity was better (short distance,
with a low level of linearity) for all groups of rats during the
last 5min of place avoidance training (tr2) than in the other
conditions.
CONCLUSION
We found that, independent of dose, memantine and MK-
80 have different effects on cognitive and non-cognitive func-
tions. Furthermore, dose-dependent effects were found in which
memantine in a low dose involved short-lasting improvement in
spatial working memory. MK-801 in a low dose, which was found
to produce schizophrenia-like symptoms in an animal model,
supported working memory performance at the level of the con-
trol rats. Both agents in low doses had no effect on non-cognitive
functions.
Severe impairment of working memory and disturbance in
locomotor activity were produced by the high dose of MK-801
already on the first training session, whereas similar effects with
the high dose of memantine developed over time. Differential
results for the intra- and across session effects were found for the
cognitive processes, working memory and CSL, which confirms
that these components reflect the heterogeneous nature of the
working memory system. No delayed (long-term) effects of previ-
ous drug treatment, except for high dose of memantine, on either
cognitive or non-cognitive functions were observed. After a long
break without memantine and MK-801 treatment performance
was associated with proper working memory and locomotor
activity comparable to that of controls. Interestingly, the high
dose of MK-801 resulted in improved cognitive performance 18
days after the last drug administration.
The APAAT method offers a valuable and unique behav-
ioral tool to simultaneously compare cognitive and non-cognitive
functions under pharmacological intervention. In this study
specifically NMDAr blockade, which can help develop concrete
models for the therapeutic treatment of neurodegenerative dis-
orders and diseases related to excitotoxicity, was employed. This
expands the value of the APAAT beyond its capacity to measure
working memory and CSL (Dockery and Wesierska, 2010).
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